Hyperuricemia and Hypertension: A Confluence of Concepts

作者: Andrew Whelton

DOI: 10.1161/HYPERTENSIONAHA.112.198341

关键词:

摘要: See related article, pp 1148–1156 Rarely in clinical medicine is it possible to define a distinct laboratory abnormality associated, for unknown reasons, with specific disease entity and have one group of tenacious investigators resolve the conundrum contributing mechanisms. Nonetheless, this issue Hypertension such case as presented investigations Soletsky Feig.1 These now contributed decade or more animal human investigation by Feig Johnson their coworkers unraveling major mechanism that links hyperuricemia hypertension. This has been long-standing basic science quest.2 Gout, long-term manifestation hyperuricemia, metabolic process known from antiquity. Egyptian physicians described some 5000 years ago followed astute characterization disease, fifth century BC, Greek physician Hippocrates, “the unwalkable disease.”3 By mid-1800s AD Sir Alfred Baring Garod identified uric acid was cause gout not consequence disease. In addition, also coincided time framework which several speculated on linkage presence However, until contemporary studies colleagues we learned that, models, acute elevation serum urate induces prompt blood pressure chronic sustains abnormal irreversible vascular glomerular changes lead form salt-sensitive hypertension.4,5 Hence, lesson suggested humans, early treatment reduce associated increases might be successful, whereas attendant emergence …

参考文章(12)
Yanyan Zhu, Bhavik J. Pandya, Hyon K. Choi, Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007–2008 Arthritis & Rheumatism. ,vol. 63, pp. 3136- 3141 ,(2011) , 10.1002/ART.30520
Navdeep Tangri, Daniel E. Weiner, Uric Acid, CKD, and Cardiovascular Disease: Confounders, Culprits, and Circles American Journal of Kidney Diseases. ,vol. 56, pp. 247- 250 ,(2010) , 10.1053/J.AJKD.2010.06.004
Lauren F. Loeffler, Ana Navas-Acien, Tammy M. Brady, Edgar R. Miller, Jeffrey J. Fadrowski, Uric Acid Level and Elevated Blood Pressure in US Adolescents Hypertension. ,vol. 59, pp. 811- 817 ,(2012) , 10.1161/HYPERTENSIONAHA.111.183244
Daniel I. Feig, Beth Soletsky, Richard J. Johnson, Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension JAMA. ,vol. 300, pp. 924- 932 ,(2008) , 10.1001/JAMA.300.8.924
Marilda Mazzali, John Kanellis, Lin Han, Lili Feng, Yi-Yang Xia, Qiang Chen, Duk-Hee Kang, Katherine L. Gordon, Susumu Watanabe, Takahiko Nakagawa, Hui Y. Lan, Richard J. Johnson, Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism American Journal of Physiology-renal Physiology. ,vol. 282, ,(2002) , 10.1152/AJPRENAL.00283.2001
Beth Soletsky, Daniel I. Feig, Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents Hypertension. ,vol. 60, pp. 1148- 1156 ,(2012) , 10.1161/HYPERTENSIONAHA.112.196980
George Nuki, Peter A Simkin, A concise history of gout and hyperuricemia and their treatment Arthritis Research & Therapy. ,vol. 8, pp. 1- 5 ,(2006) , 10.1186/AR1906
Karen L. Price, Yuri Y. Sautin, David A. Long, Li Zhang, Hiroki Miyazaki, Wei Mu, Hitoshi Endou, Richard J. Johnson, Human Vascular Smooth Muscle Cells Express a Urate Transporter Journal of The American Society of Nephrology. ,vol. 17, pp. 1791- 1795 ,(2006) , 10.1681/ASN.2006030264
Marilda Mazzali, Jeremy Hughes, Yoon-Goo Kim, J. Ashley Jefferson, Duk-Hee Kang, Katherine L. Gordon, Hui Y. Lan, Salah Kivlighn, Richard J. Johnson, Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism Hypertension. ,vol. 38, pp. 1101- 1106 ,(2001) , 10.1161/HY1101.092839
Daniel I. Feig, Duk-Hee Kang, Richard J. Johnson, Uric acid and cardiovascular risk. The New England Journal of Medicine. ,vol. 359, pp. 1811- 1821 ,(2008) , 10.1056/NEJMRA0800885